Skip to main content
HCPCS J1460 · Level II · Part B drug

J1460: gamma globulin (Gamastan), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1460

Billing unit
1 CC
Gamma globulin 1 cc inj
ASP payment limit
$48.946
October 2026; +0.2% vs July 2026
Practitioner MUE
10
MAI 2
OPPS status
SI K
APC 1850
NCCI exposure
1 col-2 pairs
0% allow a modifier
Coverage articles
2
6 states

TL;DR

HCPCS J1460 is the Level II code for Injection, gamma globulin, intramuscular, 1 cc, billed per 1 CC. The Medicare Part B ASP payment limit for October 2026 is $48.946 per billing unit, up 0.2% from July 2026. The practitioner MUE allows up to 10 units per date of service (MAI 2), so a full 10-unit day is $489.46 at the current limit. Under OPPS it carries status indicator K in APC 1850. J1460 is billed in units of 1 CC; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names gamma globulin: J1560 (billed per 10 cc). The ASP crosswalk maps 2 NDCs to it, sold as Gamastan by Grifols USA, LLC. It is the bundled column-2 code in 1 NCCI pair, most often with J1560. 2 Medicare coverage articles list the code across 6 states, including A57160.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1460 at $48.946 per 1 CC for October 2026, derived from manufacturer average sales price plus 6%, compared with $48.874 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J1460
QuarterPayment limitPerCoinsurance
October 2026$48.9461 CC20%
July 2026$48.8741 CC—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 2 NDCs from 1 labeler to J1460. Report the NDC in the claim's drug segment and bill the number of J1460 units that equals the quantity administered divided by 1 CC; the last column gives units per full package.

NDCs that crosswalk to J1460
NDCDrug nameLabelerPackage sizeBilling units / package
13533-0335-04GamastanGrifols USA, LLC2 × 12
13533-0335-12GamastanGrifols USA, LLC10 × 110

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J1460. For practitioners the limit is 10 units per date of service with adjudication indicator 2, a date-of-service policy edit: the limit reflects CMS policy and units above it deny even if split across lines; appeals rarely succeed.

MUE values for J1460 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services102 Date of Service Edit: PolicyCode Descriptor / CPT Instruction
Facility outpatient hospital102 Date of Service Edit: PolicyCode Descriptor / CPT Instruction
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J1460 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

In the practitioner PTP file v323r0 (effective October 1, 2026), J1460 is the column-2 code in 1 active pair, 0% of which allow a modifier (indicator 1), and the column-1 code in 0. 9 historical pairs have been deleted over time. CMS's most frequent rationale: More extensive procedure.

When billed with these column-1 codes, J1460 is the bundled component unless the pair allows a modifier and the documentation supports a distinct service.

Column-1 codes most often paired with J1460
Column-1 codePairs
J1560 Gamma globulin > 10 cc inj1

The counts above are exposure, not answers for a specific claim. Check J1460 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1460 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

2 current Medicare Administrative Contractor articles list J1460 in their HCPCS tables, covering 6 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J1460
ArticleTitleContractor(s)StatesRelated LCD
A57160Billing and Coding: Immune Thrombocytopenia (ITP) TherapyCGS Administrators, LLCKY OHL38268
A57554Billing and Coding: Immune GlobulinsWisconsin Physicians Service Insurance CorporationIA KS MO NEL34771

Diagnoses Medicare contractors cover for J1460

2 billing and coding articles attach a covered diagnosis list to J1460: 23 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 15 covered ICD-10-CM codes for J1460
ICD-10-CMDescription (FY2027)Articles covering
D69.3Immune thrombocytopenic purpura1 of 2
D80.0Hereditary hypogammaglobulinemia1 of 2
D80.1Nonfamilial hypogammaglobulinemia1 of 2
D80.2Selective deficiency of immunoglobulin A [IgA]1 of 2
D80.3Selective deficiency of immunoglobulin G [IgG] subclasses1 of 2
D80.4Selective deficiency of immunoglobulin M [IgM]1 of 2
D80.5Immunodeficiency with increased immunoglobulin M [IgM]1 of 2
D81.0Severe combined immunodeficiency [SCID] with reticular dysgenesis1 of 2
D81.1Severe combined immunodeficiency [SCID] with low T- and B-cell numbers1 of 2
D81.2Severe combined immunodeficiency [SCID] with low or normal B-cell numbers1 of 2
D81.6Major histocompatibility complex class I deficiency1 of 2
D81.7Major histocompatibility complex class II deficiency1 of 2
D81.82Activated Phosphoinositide 3-kinase Delta Syndrome [APDS]1 of 2
D81.89Other combined immunodeficiencies1 of 2
D81.9Combined immunodeficiency, unspecified1 of 2
8 more codes are in the full lists linked below.

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J1460 are counted here: a group whose instructions name J1460, together with any unnamed groups directly after it, read as continuations of those instructions. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to J1460, by article
ArticleContractorGroups that applyCovered codes for J1460Full list
A57160CGS Administrators, LLCone list for every code in the article1On LCD L38268
A57554Wisconsin Physicians Service Insurance Corporationgroups 1 and 2 apply to J146022On LCD L34771

Local coverage policies that list J1460

2 active Local Coverage Determinations list J1460 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1460 carries status indicator K and is assigned to APC 1850, with a published national unadjusted payment of $48.946. Status K means the drug is paid separately under OPPS at the ASP-based rate rather than packaged into the procedure.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1460 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $48.95 per 1 CC, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for J1460 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1460

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1460

What does HCPCS code J1460 describe?

J1460 is defined by CMS as "Injection, gamma globulin, intramuscular, 1 cc". Each billing unit represents 1 CC, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1460 a CPT code?

No. J1460 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as gamma globulin (Gamastan); CPT codes are five-character codes maintained by the AMA. On a Part B claim J1460 reports the drug itself in 1 cc units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1460 in October 2026?

The ASP-based payment limit is $48.946 per 1 CC, with 20% beneficiary coinsurance. The July 2026 limit was $48.874. Commercial payers use their own fee schedules.

How many units of J1460 can be billed per day?

The practitioner Medically Unlikely Edit is 10 units per date of service with adjudication indicator 2 (Date of Service Edit: Policy). MAI 2 edits are policy limits and are rarely overturned on appeal. CMS cites "Code Descriptor / CPT Instruction" as the rationale.

Which NDCs map to J1460?

The October 2026 ASP crosswalk lists 2 NDCs from 1 labeler: Gamastan (Grifols USA, LLC). For example NDC 13533-0335-04 (package size 2) equals 2 billing units of J1460.

Does J1460 have NCCI bundling edits?

In the v323r0 practitioner PTP file, J1460 appears as the column-2 (bundled) code in 1 active pairs and as the column-1 code in 0. 0% of the column-2 pairs allow a modifier (indicator 1). The most frequent column-1 partners are J1560, and CMS's leading rationale is "More extensive procedure".

J1460 vs J1560: what is the difference?

Both are HCPCS Level II codes whose descriptor names gamma globulin. What sets J1560 apart: billed per 10 cc. J1460 is billed per 1 cc, limit $48.946, MUE 10; J1560 is billed per 10 cc, limit $118.153, MUE 1. Report the code whose descriptor matches the product and setting in the record.

Which Medicare coverage articles mention J1460?

2 current Billing and Coding Articles in the Medicare Coverage Database list J1460, covering 6 states: A57160 (Billing and Coding: Immune Thrombocytopenia (ITP) Therapy); A57554 (Billing and Coding: Immune Globulins).

What diagnosis codes support J1460?

2 Medicare billing and coding articles list 23 covered ICD-10-CM codes for J1460 between them, for example D69.3 (Immune thrombocytopenic purpura); D80.0 (Hereditary hypogammaglobulinemia); D80.1 (Nonfamilial hypogammaglobulinemia); D80.2 (Selective deficiency of immunoglobulin A [IgA]); D80.3 (Selective deficiency of immunoglobulin G [IgG] subclasses). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.